SOLVAC SA-REG (SOLV.BR) Fundamental Analysis & Valuation

EBR:SOLV • BE0003545531

67 EUR
+0.6 (+0.9%)
Last: Mar 3, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership

This SOLV.BR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

4

Overall SOLV gets a fundamental rating of 4 out of 10. We evaluated SOLV against 66 industry peers in the Chemicals industry. Both the profitability and the financial health of SOLV get a neutral evaluation. Nothing too spectacular is happening here. SOLV has a valuation in line with the averages, but on the other hand it scores bad on growth. SOLV also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

5

1. SOLV.BR Profitability Analysis

1.1 Basic Checks

  • In the past year SOLV was profitable.
  • SOLV had positive earnings in 4 of the past 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: SOLV reported negative operating cash flow in multiple years.
SOLV.BR Yearly Net Income VS EBIT VS OCF VS FCFSOLV.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M

1.2 Ratios

  • SOLV's Return On Assets of 4.55% is fine compared to the rest of the industry. SOLV outperforms 62.12% of its industry peers.
  • SOLV has a Return On Equity (5.00%) which is in line with its industry peers.
  • SOLV has a Return On Invested Capital (3.65%) which is comparable to the rest of the industry.
  • The Average Return On Invested Capital over the past 3 years for SOLV is below the industry average of 6.96%.
  • The 3 year average ROIC (3.44%) for SOLV is below the current ROIC(3.65%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.55%
ROE 5%
ROIC 3.65%
ROA(3y)4.3%
ROA(5y)2.1%
ROE(3y)4.67%
ROE(5y)2.26%
ROIC(3y)3.44%
ROIC(5y)N/A
SOLV.BR Yearly ROA, ROE, ROICSOLV.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

  • With an excellent Profit Margin value of 95.09%, SOLV belongs to the best of the industry, outperforming 98.48% of the companies in the same industry.
  • In the last couple of years the Profit Margin of SOLV has grown nicely.
  • SOLV's Operating Margin of 97.93% is amongst the best of the industry. SOLV outperforms 100.00% of its industry peers.
  • In the last couple of years the Operating Margin of SOLV has grown nicely.
Industry RankSector Rank
OM 97.93%
PM (TTM) 95.09%
GM N/A
OM growth 3Y-0.21%
OM growth 5Y2.47%
PM growth 3Y-1.44%
PM growth 5Y1.71%
GM growth 3YN/A
GM growth 5YN/A
SOLV.BR Yearly Profit, Operating, Gross MarginsSOLV.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 100 200 300 400

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. SOLV.BR Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, SOLV has about the same amount of shares outstanding.
  • Compared to 5 years ago, SOLV has about the same amount of shares outstanding.
  • Compared to 1 year ago, SOLV has an improved debt to assets ratio.
SOLV.BR Yearly Shares OutstandingSOLV.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
SOLV.BR Yearly Total Debt VS Total AssetsSOLV.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

  • An Altman-Z score of 4.51 indicates that SOLV is not in any danger for bankruptcy at the moment.
  • SOLV has a better Altman-Z score (4.51) than 89.39% of its industry peers.
  • A Debt/Equity ratio of 0.06 indicates that SOLV is not too dependend on debt financing.
  • SOLV's Debt to Equity ratio of 0.06 is amongst the best of the industry. SOLV outperforms 89.39% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Altman-Z 4.51
ROIC/WACCN/A
WACCN/A
SOLV.BR Yearly LT Debt VS Equity VS FCFSOLV.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

  • A Current Ratio of 0.69 indicates that SOLV may have some problems paying its short term obligations.
  • The Current ratio of SOLV (0.69) is worse than 90.91% of its industry peers.
  • SOLV has a Quick Ratio of 0.69. This is a bad value and indicates that SOLV is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Quick ratio value of 0.69, SOLV is not doing good in the industry: 83.33% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.69
Quick Ratio 0.69
SOLV.BR Yearly Current Assets VS Current LiabilitesSOLV.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. SOLV.BR Growth Analysis

3.1 Past

  • SOLV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -38.57%.
  • The Earnings Per Share has been growing by 26.70% on average over the past years. This is a very strong growth
  • SOLV shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -38.28%.
  • The Revenue has been growing by 24.62% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-38.57%
EPS 3Y-29.04%
EPS 5Y26.7%
EPS Q2Q%28%
Revenue 1Y (TTM)-38.28%
Revenue growth 3Y-28%
Revenue growth 5Y24.62%
Sales Q2Q%26.75%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y6.67%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.68%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SOLV.BR Yearly Revenue VS EstimatesSOLV.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B
SOLV.BR Yearly EPS VS EstimatesSOLV.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 5 10

More info and screens

Find the best growth stocksShow best growing peers

5

4. SOLV.BR Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 11.38, the valuation of SOLV can be described as reasonable.
  • Based on the Price/Earnings ratio, SOLV is valued cheaply inside the industry as 93.94% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Earnings ratio of 26.83, SOLV is valued rather cheaply.
  • Based on the Price/Forward Earnings ratio of 4.61, the valuation of SOLV can be described as very cheap.
  • 100.00% of the companies in the same industry are more expensive than SOLV, based on the Price/Forward Earnings ratio.
  • SOLV is valuated cheaply when we compare the Price/Forward Earnings ratio to 24.95, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 11.38
Fwd PE 4.61
SOLV.BR Price Earnings VS Forward Price EarningsSOLV.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SOLV.BR Per share dataSOLV.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.71
PEG (5Y)0.43
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

7

5. SOLV.BR Dividend Analysis

5.1 Amount

  • SOLV has a Yearly Dividend Yield of 5.50%, which is a nice return.
  • SOLV's Dividend Yield is rather good when compared to the industry average which is at 2.21. SOLV pays more dividend than 89.39% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, SOLV pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.5%

5.2 History

  • The dividend of SOLV has a limited annual growth rate of 1.34%.
Dividend Growth(5Y)1.34%
Div Incr Years0
Div Non Decr Years0
SOLV.BR Yearly Dividends per shareSOLV.BR Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3 4 5

5.3 Sustainability

  • SOLV's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DPN/A
EPS Next 2YN/A
EPS Next 3YN/A
SOLV.BR Yearly Income VS Free CF VS DividendSOLV.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M

More info and screens

Find the best dividend stocksShow peers with best dividend

SOLV.BR Fundamentals: All Metrics, Ratios and Statistics

SOLVAC SA-REG

EBR:SOLV (3/3/2026, 7:00:00 PM)

67

+0.6 (+0.9%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-06
Earnings (Next)03-06
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners5.24%
Ins Owner ChangeN/A
Market Cap1.43B
Revenue(TTM)132.44M
Net Income(TTM)125.93M
Analysts44
Price Target108.27 (61.6%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.5%
Yearly Dividend5.8
Dividend Growth(5Y)1.34%
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-13.21%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 11.38
Fwd PE 4.61
P/S 10.82
P/FCF N/A
P/OCF N/A
P/B 0.57
P/tB 0.57
EV/EBITDA N/A
EPS(TTM)5.89
EY8.79%
EPS(NY)14.52
Fwd EY21.68%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS6.19
BVpS117.7
TBVpS117.7
PEG (NY)1.71
PEG (5Y)0.43
Graham Number124.89
Profitability
Industry RankSector Rank
ROA 4.55%
ROE 5%
ROCE 4.86%
ROIC 3.65%
ROICexc 3.74%
ROICexgc 3.74%
OM 97.93%
PM (TTM) 95.09%
GM N/A
FCFM N/A
ROA(3y)4.3%
ROA(5y)2.1%
ROE(3y)4.67%
ROE(5y)2.26%
ROIC(3y)3.44%
ROIC(5y)N/A
ROICexc(3y)3.44%
ROICexc(5y)N/A
ROICexgc(3y)3.61%
ROICexgc(5y)N/A
ROCE(3y)4.58%
ROCE(5y)N/A
ROICexgc growth 3Y-27.07%
ROICexgc growth 5Y31.12%
ROICexc growth 3Y-24.14%
ROICexc growth 5Y34%
OM growth 3Y-0.21%
OM growth 5Y2.47%
PM growth 3Y-1.44%
PM growth 5Y1.71%
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.69
Quick Ratio 0.69
Altman-Z 4.51
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-38.57%
EPS 3Y-29.04%
EPS 5Y26.7%
EPS Q2Q%28%
EPS Next Y6.67%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-38.28%
Revenue growth 3Y-28%
Revenue growth 5Y24.62%
Sales Q2Q%26.75%
Revenue Next Year3.68%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-38.25%
EBIT growth 3Y-28.15%
EBIT growth 5Y27.7%
EBIT Next Year44.79%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y35.44%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y35.44%
OCF growth 3YN/A
OCF growth 5YN/A

SOLVAC SA-REG / SOLV.BR FAQ

Can you provide the ChartMill fundamental rating for SOLVAC SA-REG?

ChartMill assigns a fundamental rating of 4 / 10 to SOLV.BR.


What is the valuation status of SOLVAC SA-REG (SOLV.BR) stock?

ChartMill assigns a valuation rating of 5 / 10 to SOLVAC SA-REG (SOLV.BR). This can be considered as Fairly Valued.


Can you provide the profitability details for SOLVAC SA-REG?

SOLVAC SA-REG (SOLV.BR) has a profitability rating of 5 / 10.


How financially healthy is SOLVAC SA-REG?

The financial health rating of SOLVAC SA-REG (SOLV.BR) is 4 / 10.